A new study extended the period of treatment for patients with Hepatitis C on Sofosbuvir and Ribavirin to test whether SVF12 rates can be attained in real-life.
In a recent meta-analysis, researchers investigated the risk of gastrointestinal bleeding with daily aspirin use, specifically examining the risk of fatal events attributable to low-dose aspirin.
Researchers assessed direct-acting antiviral agents and availability of funding to determine the impact on ability to treat and cure veterans with hepatitis C virus.
This is the first study to examine fungus as a potential cause of Crohn disease. Researchers examined bacteriome and mycobiome in patients with Crohn disease and compared the results with patients’ healthy...
A recent study aimed to determine the impact of treatment adherence to sofosbuvir-based regimens on virological outcomes in patients with hepatitis C virus.
Research discussed at an international symposium suggests that treating people who use drugs and have hepatitis C virus can reduce the prevalence of the infection. However, barriers prevent this population...
